Buckingham Strategic Partners Mannkind Corp Transaction History
Buckingham Strategic Partners
- $5.48 Billion
- Q4 2024
A detailed history of Buckingham Strategic Partners transactions in Mannkind Corp stock. As of the latest transaction made, Buckingham Strategic Partners holds 17,301 shares of MNKD stock, worth $97,923. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,301Holding current value
$97,923% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MNKD
# of Institutions
260Shares Held
161MCall Options Held
1.97MPut Options Held
943K-
Black Rock Inc. New York, NY22.6MShares$128 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$90.9 Million0.0% of portfolio
-
State Street Corp Boston, MA9.95MShares$56.3 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$49.5 Million0.82% of portfolio
-
Nitorum Capital, L.P. New York, NY8.75MShares$49.5 Million8.23% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.46B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...